Agreement of Turkish physiatrists with the assessment in spondyloarthritis international society and the European league against rheumatism recommendations for the management of ankylosing spondylitis and rheumatoid arthritis

Basit Öğe Kaydı
dc.authorscopusid7003693574
dc.authorscopusid59091058000
dc.authorscopusid7003868980
dc.authorscopusid6602238566
dc.authorscopusid6602700193
dc.authorscopusid7004099237
dc.authorscopusid55953731500
dc.contributor.authorOzgocmen S.
dc.contributor.authorAkgul O.
dc.contributor.authorAkinci A.
dc.contributor.authorAtaman S.
dc.contributor.authorBirtane M.
dc.contributor.authorBodur H.
dc.contributor.authorGünaydin R.
dc.date.accessioned2024-06-12T10:25:48Z
dc.date.available2024-06-12T10:25:48Z
dc.date.issued2012
dc.description.abstractBackground: New developments in the field of targeted therapies or biologic agents led more effective management of ankylosing spondylitis (AS) and rheumatoid arthritis (RA). Recommendations for the management of rheumatic diseases propose to reduce inappropriate use of medications, minimize variations among countries, and enable cost-effective use of health care resources. Objective: The aim this study was to evaluate conceptual agreement of ASsessment in SpondyloArthritis International Society (ASAS) and the EUropean League Against Rheumatism (EULAR) recommendations for the management of AS and EULAR recommendations for RA and to assess the rate of application among Turkish physiatrists in daily clinical practice. Methods: An online survey link has been sent to 1756 Turkish physiatrists with e-mails asking to rate agreement on 11 item ASAS/EULAR AS recommendations and 15-item EULAR RA recommendations with synthetic and biological disease-modifying anti-rheumatic drugs. Also barriers and difficulties for using biologic agents were assessed. Results: Three hundred nine physiatrists (17.5%) completed the survey. The conceptual agreement with both recommendations was very high (Level of agreement; mean 8.35±0.82 and 8.90± 0.67 for RA and AS recommendations, respectively), and the self-declared application of overall recommendations in the clinical practice was also high for both RA and AS (72.42% and 75.71%, respectively). Conclusion: Turkish physiatrists are in good conceptual agreement with the evidence-based recommendations for the management of AS and RA. These efforts may serve to disseminate the knowledge and increase the current awareness among physicians who serve to these patients and also implementation of these recommendations is expected to increase as well. © Ozgocmen et al.en_US
dc.identifier.doi10.2174/1874312901206010001
dc.identifier.endpage5en_US
dc.identifier.issn1874-3129
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84859496040en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.2174/1874312901206010001
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16526
dc.identifier.volume6en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofOpen Rheumatology Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAgreement; Ankylosing Spondylitis; Physiatrist; Recommendations; Rheumatoid Arthritisen_US
dc.subjectDisease Modifying Antirheumatic Drug; Ankylosing Spondylitis; Article; Clinical Practice; Cost Effectiveness Analysis; E-Mail; Evidence Based Medicine; Health Care Utilization; Health Survey; Human; Medical Society; Online System; Physical Medicine; Priority Journal; Rheumatoid Arthritisen_US
dc.titleAgreement of Turkish physiatrists with the assessment in spondyloarthritis international society and the European league against rheumatism recommendations for the management of ankylosing spondylitis and rheumatoid arthritisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu